Crowdonomics
SEN-JAM PHARMACEUTICAL

Reg CF · Convertible Note · Jun 2025

ClosedReg CFConvertible Note
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $3.3M max
0% of ceiling · target hit day 9
Investors
—
—
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$1.5M$737K$0
5352680
Jun 20, 2025 · openedFeb 4, 2026 · last reading
Target ($50K) hit — Jun 29, 2025, day 9$1.0M raised — Nov 24, 2025Deadline Apr 30, 2026 — 85 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder, last checked Aug 17, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$4.4M
FY2023
$0
−$4.5M
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$4,355,706
-$4,475,577
Taxes paid
$0
$0
Balance sheet
Cash
$331,764
$579,282
Accounts receivable
$0
$0
Total assets
$950,081
$1,294,445
Short-term debt
$1,111,512
$2,762,742
Long-term debt
$1,756,115
$2,239,984
Total liabilities
$2,867,627
$5,002,726
Other
Headcount
5
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$50,000
Max$3,319,224
Min investment—
OpenedJun 20, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active314

Links & provenance

Source: SEC EDGAR
0001670254-25-000661
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.